rs144808884
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting
The NM_001206927.2(DNAH8):c.12656G>A(p.Arg4219Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000366 in 1,603,952 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001206927.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAH8 | NM_001206927.2 | c.12656G>A | p.Arg4219Gln | missense_variant | 84/93 | ENST00000327475.11 | NP_001193856.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAH8 | ENST00000327475.11 | c.12656G>A | p.Arg4219Gln | missense_variant | 84/93 | 5 | NM_001206927.2 | ENSP00000333363 | P2 | |
DNAH8 | ENST00000359357.7 | c.12005G>A | p.Arg4002Gln | missense_variant | 82/91 | 2 | ENSP00000352312 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000362 AC: 55AN: 152080Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000194 AC: 46AN: 237330Hom.: 0 AF XY: 0.000156 AC XY: 20AN XY: 128332
GnomAD4 exome AF: 0.000366 AC: 532AN: 1451754Hom.: 1 Cov.: 29 AF XY: 0.000323 AC XY: 233AN XY: 722002
GnomAD4 genome AF: 0.000361 AC: 55AN: 152198Hom.: 0 Cov.: 32 AF XY: 0.000282 AC XY: 21AN XY: 74402
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 11, 2024 | The c.12656G>A (p.R4219Q) alteration is located in exon 84 (coding exon 83) of the DNAH8 gene. This alteration results from a G to A substitution at nucleotide position 12656, causing the arginine (R) at amino acid position 4219 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Primary ciliary dyskinesia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 01, 2022 | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 4219 of the DNAH8 protein (p.Arg4219Gln). This variant is present in population databases (rs144808884, gnomAD 0.08%). This missense change has been observed in individual(s) with features of primary ciliary dyskinesia (Invitae). ClinVar contains an entry for this variant (Variation ID: 407304). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at